Neurocrine Biosciences Reports Second Quarter 2008 Results SAN DIEGO, July 30 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc.today announced its financial results for the quarter ended June 30, 2008.
For the second quarter of 2008, the Company reported a net loss of $21.0 million, or $(0...
Neurocrine Biosciences Reports Second Quarter 2008 Results SAN DIEGO, July 30 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc.(Nasdaq: NBIX) today announced its financial results for the quarter ended June 30, 2008.
For the second quarter of 2008, the Company reported a net loss of $21.0...
Santarus and Depomed Announce U.S. Promotion Agreement for GLUMETZA Prescription Products Santarus, Inc.(NASDAQ: SNTS) and Depomed, Inc.
(NASDAQ: DEPO) today announced that they have entered into a promotion agreement granting Santarus exclusive rights to promote Depomed's GLUMETZA (metformin hydrochloride extended...
Santarus and Depomed Announce U.S. Promotion Agreement for GLUMETZA Prescription Products Santarus to sponsor conference call at 10:00 a.m.Eastern time today SAN DIEGO & MENLO PARK, Calif.--(HSMN NewsFeed)--Santarus, Inc.
(NASDAQ: SNTS ) and Depomed, Inc.
(NASDAQ: DEPO ) today announced that they have entered...
Depomed gets product OK, grant from Michael J. Fox Foundation Depomed (NASDAQ: DEPO) can now market the ProQuin XR treatment for urinary tract infections in Sweden, where its European licensee, Rottapharm|Madaus, based in Monza, Italy, will sell it.Carl Pelzel, president and CEO of Depomed,...
Depomed gets product OK, grant from Michael J. Fox Foundation Depomed (NASDAQ: DEPO) can now market the ProQuin XR treatment for urinary tract infections in Sweden, where its European licensee, Rottapharm|Madaus, based in Monza, Italy, will sell it.Carl Pelzel, president and CEO of Depomed,...
Santarus and Depomed Announce U.S. Promotion Agreement for Glumetza Prescription Products - Santarus, Inc.(NASDAQ: SNTS) and Depomed, Inc.
(NASDAQ: DEPO) today announced that they have entered into a promotion agreement granting Santarus exclusive rights to promote Depomed's GLUMETZA(R) (metformin hydrochloride...
Santarus and Depomed Announce U.S. Promotion Agreement for GLUMETZA Prescription Products - Santarus, Inc.(NASDAQ: SNTS) and Depomed, Inc.
(NASDAQ: DEPO) today announced that they have entered into a promotion agreement granting Santarus exclusive rights to promote Depomed's GLUMETZA(R) (metformin hydrochloride...
Santarus To Promote Depomed Diabetes Treatment (FinancialWire) Santarus Inc.(NASDAQ: SNTS) (Current Market Cap.
US$121.62 Mil.) and Depomed Inc.
(NASDAQ: DEPO) (Current Market Cap.
US$193.07) have entered into a promotion agreement granting Santarus exclusive rights to...
Santarus and Depomed Announce U.S. Promotion Agreement for Glumetza Prescription Products - Santarus, Inc.(NASDAQ: SNTS) and Depomed, Inc.
(NASDAQ: DEPO) today announced that they have entered into a promotion agreement granting Santarus exclusive rights to promote Depomed's GLUMETZA(R) (metformin hydrochloride...
Santarus and Depomed Announce U.S. Promotion Agreement for GLUMETZA Prescription Products , 7:00 AM EST News source: Business Wire Santarus, Inc.(NASDAQ: SNTS) and Depomed, Inc.
(NASDAQ: DEPO) today announced that they have entered into a promotion agreement granting Santarus exclusive rights to promote Depomed's...
Santarus and Depomed Announce U.S. Promotion Agreement for GLUMETZA Prescription Products Author : CA-SANTARUS/DEPOMED Category : Press Release News Alerts by Email click here ) News | Home SAN DIEGO & MENLO PARK, Calif.- (Business Wire) Santarus, Inc.
(NASDAQ: SNTS) and Depomed, Inc.
(NASDAQ: DEPO) today...
Pfizer job cuts don't equal a reduction in work load, says company spokesman BY AL JONES ajones@kalamazoogazette.com 388-8556 KALAMAZOO -- Job cuts at Pfizer's manufacturing operation in Portage will leave the company with 275 fewer workers but just as much work to do, a company spokesman says.''We believe that...
Pfizer To Cut 275 Jobs At Michigan Manufacturing Plant, To Boost Efficiency (FinancialWire) Pfizer Inc.(NYSE: PFE) said that it is cutting 275 jobs at its biggest manufacturing plant, in Kalamazoo, Michigan, as part of a restructuring project aimed at cutting costs by $1.5 billion to $2 billion by the end of this...
Pfizer eliminates 275 jobs, all in Kalamazoo :Restructuring involves drug firm's largest plant Restructuring involves drug firm's largest plant.KALAMAZOO (AP) -- Pfizer Inc.
is cutting 275 jobs in Kalamazoo at its biggest manufacturing plant in its latest restructuring move.
The job eliminations will affect supervisory and...
Pfizer eliminates 275 jobs, all in Kalamazoo Restructuring involves drug firm's largest plant.KALAMAZOO (AP) -- Pfizer Inc.
is cutting 275 jobs in Kalamazoo at its biggest manufacturing plant in its latest restructuring move.
The job eliminations will affect supervisory and...
Pfizer cutting 275 jobs at Michigan plant KALAMAZOO, Mich., Pfizer Inc.is cutting 275 jobs at its biggest manufacturing plant, in Michigan, in its latest restructuring move.
The job eliminations in Kalamazoo will affect supervisory and support staff, and some operational staff...
Pfizer cutting 275 jobs at Michigan plant KALAMAZOO, Mich., Pfizer Inc.is cutting 275 jobs at its biggest manufacturing plant, in Michigan, in its latest restructuring move.
The job eliminations in Kalamazoo will affect supervisory and support staff, and some operational staff...
Pfizer to cut 275 jobs at Kalamazoo plant KALAMAZOO -- Pfizer Inc.is cutting 275 jobs at its biggest manufacturing plant, in Michigan, in its latest restructuring move.
The job eliminations in Kalamazoo will affect supervisory and support staff, and some operational staff such...
Pfizer to cut 275 jobs at Kalamazoo plant KALAMAZOO - Pfizer Inc.is cutting 275 jobs at its biggest manufacturing plant, in Michigan, in its latest restructuring move.
The job eliminations in Kalamazoo will affect supervisory and support staff, and some operational staff such...
Pfizer Cutting 275 Jobs at Michigan Plant KALAMAZOO, Mich.(AP) - Pfizer Inc.
is cutting 275 jobs at its biggest manufacturing plant, in Michigan, in its latest restructuring move.
The job eliminations in Kalamazoo will affect supervisory and support staff, and some...
Pfizer to lay off 275 at Michigan plant Pfizer Inc.is cutting 275 jobs at its biggest manufacturing plant, in Michigan, in its latest restructuring move.
The job eliminations in Kalamazoo will affect supervisory and support staff, and some operational staff such as project...
Pfizer cutting 275 jobs at Michigan plant KALAMAZOO - Pfizer Inc.is cutting 275 jobs at its biggest manufacturing plant, in Michigan, in its latest restructuring move.
The job eliminations in Kalamazoo will affect supervisory and support staff, and some operational staff such...
Pfizer to cut 275 jobs at Kalamazoo plant KALAMAZOO -- Pfizer Inc.is cutting 275 jobs at its biggest manufacturing plant, in Michigan, in its latest restructuring move.
The job eliminations in Kalamazoo will affect supervisory and support staff, and some operational staff such...
Pfizer cutting 275 jobs at Michigan plant BY ASSOCIATED PRESS KALAMAZOO, Mich.-- Pfizer Inc.
is cutting 275 jobs at its biggest manufacturing plant, in Michigan, in its latest restructuring move.
The job eliminations in Kalamazoo will affect supervisory and support staff, and...
